COOPER COMPANIES, INC.
COO
Latest Filing: Jun 5, 2026 • 25 Total Filings
Total Assets
2026
$12.48B
Total Revenue
2026
$1.08B
Net Income
2026
$-77.90M
Operating Cash Flow
2026
N/A
Filing Year:
2025
Only 2025 data available
Data Source:
Showing data from all document types
Filters:
competes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes withcompetes with
COOPER COMPANIES, INC.
Ticker: COO
Johnson & Johnson
Various therapeutic areas
Major Competitor
Johnson & Johnson Vision Care, Inc.
Spherical, toric and multifocal contact lens categories
Major Competitor
Alcon Inc.
Spherical, toric and multifocal contact lens categories
Major Competitor
Bausch + Lomb
Spherical, toric and multifocal contact lens categories
Major Competitor
Vitrolife Group
Fertility products and services
Major Competitor
Nexpring
Fertility products and services
Major Competitor
Fairfax Cryobank
Fertility products and services
Major Competitor
Fairfax EggBank
Fertility products and services
Major Competitor
Baxter International
Medical device products for women's health
Major Competitor
Medtronic
Medical device products for women's health
Major Competitor
Hologic
Medical device products for women's health
Major Competitor
ViaCord
Stem cell storage (cord blood and cord tissue)
Major Competitor
Revvity
Stem cell storage (cord blood and cord tissue)
Major Competitor
Bayer
Hormonal IUDs competing with Paragard
Major Competitor
AbbVie
Hormonal IUDs competing with Paragard
Major Competitor
Organon
Long Acting Reversible Contraceptives competing with Paragard
Major Competitor
Bausch Health Companies Inc.
Soft contact lens market, silicone hydrogel contact lenses
Major Competitor
Legend:
Company
Critical Supplier
Significant Supplier
Standard Supplier
Major Competitor
Emerging Competitor
Competitor